Phantom
I share your enthusiasm for GID but am hesitant to buy shares, as I consider
that there are a few grey areas, that are not being shared with investors,
regarding sales, timelines and possible problems down the track.
Sure it's a great idea that seems to work well, but reading the investors pages
on the GID website is like pulling teeth, there is no sales information, why?
If you have an approved game changing product that will benefit patients, doctors and
the healthcare industry ( as well of course as GID........) then
where are the facts and
timelines on potential sales and the possible return to investors.?
How many units will be sold in 2019,2020,2021,2022,2023?
What will it cost the consumer?, how much do GID make per unit?
Where is the proposed roll out of clinics?
Why are sales so slow in Europe?
What happened to the Middle East venture?
It was a $300m company, now it's a $200m company, has the
market decided that the payback time is too long?
'Projections' in a word, is what I need to make a decision, I know they
will be speculative, but I'm presently uninspired by managements efforts to disseminate
enough of the right information for me to make a decision to invest.
Maybe you know more than I ? and can help us all out with more info.
GID Price at posting:
48.0¢ Sentiment: None Disclosure: Not Held